More on IMNN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+47.4% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/16/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Imunon (NQ:IMNN)
Delayed: 1.45 -0.06 (3.97%)
Prev. Close $1.51  
Open$1.65 
52 Wk High$ 
52 Wk Low$ 
Day High$1.75 
Day Low$1.39 
P/E N/A  
EPS$ 
Volume1,101,147 

Friends, Peers and Foes (?): COCH, MTVA, SBC, STSS, TIVC (more...)

Sep 10, 2026 09:30 AM IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001
Sep 9, 2026 08:32 AM Imunon schedules R&D Day to discuss IMNN-001 ovarian cancer trials
Sep 9, 2026 08:30 AM IMUNON Announces Full Agenda and Speaker Lineup Ahead of 2026 R&D Day Highlighting IMNN-001 Clinical Progress
Aug 26, 2026 08:30 AM Imunon to host R&D day on Phase 3 ovarian cancer trial in September
Aug 26, 2026 08:30 AM Imunon to hold R&D Day on Sept. 23 focused on ovarian cancer trial
Aug 26, 2026 08:30 AM IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001 
Aug 26, 2026 08:30 AM IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001 
Aug 17, 2026 04:23 PM Form 4 Imunon, Inc. For: Aug 14 Filed by: Lindborg Stacy
Aug 17, 2026 04:22 PM Form 4 Imunon, Inc. For: Aug 14 Filed by: Faller Douglas Vincent
Aug 17, 2026 04:21 PM Form 4 Imunon, Inc. For: Aug 14 Filed by: Tardugno Michael H
View All Articles

Entities mentioned with IMNN

View All Entities